| 11/25/2014 | CVIG | S&P changes WellPoint to positive
|
| 10/29/2014 | CV | Market Commentary: Convertibles little changed ahead of the Fed; American Realty drops; Synergy prices deal
|
| 9/23/2014 | CV | Market Commentary: Morning Commentary: Planned Tesaro looks rich on the mids; Salix active amid more M&A chatter
|
| 9/11/2014 | CV | Market Commentary: Twitter’s $1.3 billion offering around issue in gray market; WellPoint drops; Tesla slips
|
| 8/7/2014 | CVIG | Moody’s rates WellPoint debt Baa2
|
| 8/7/2014 | CVIG | S&P gives A- to WellPoint debt
|
| 8/7/2014 | CVIG | Fitch rates WellPoint notes BBB
|
| 8/5/2014 | CVIG | Fitch drops WellPoint notes to BBB
|
| 7/29/2014 | CV | Market Commentary: WellPoint debt drifts down ahead of earnings; Herbalife convertibles, stock decline
|
| 7/7/2014 | CV | Market Commentary: Convertibles generally quiet; Macquarie Infrastructure on tap; Chinese internet paper eyed
|
| 7/7/2014 | CV | Market Commentary: Morning Commentary: Intel, WellPoint dominate thin post-holiday trading; Micron 3% in focus
|
| 7/3/2014 | CV | Market Commentary: NQ Mobile unmoved despite stock plunge; pre-holiday market quiet ahead of early close
|
| 5/13/2014 | CV | Market Commentary: L-3 down in huge volume on call news; Dealertrack swoons outright; Spirit Realty to price
|
| 4/17/2014 | CV | Market Commentary: Midday Commentary: Convertibles volume low; SanDisk rallies; WellPoint slips
|
| 4/16/2014 | CV | Market Commentary: Midday Commentary: WellPoint bonds active; Tesla rises in midday trading
|
| 4/16/2014 | CV | Market Commentary: Convertibles quiet as Street thins; WellPoint 'traded a lot'; Tesla Motors bonds climb
|
| 4/15/2014 | CV | Market Commentary: Convertibles quiet, volume light; WellPoint paper active; Goodrich Petroleum flat
|
| 4/10/2014 | CV | Market Commentary: Midday commentary: WellPoint flat in active trade; Priceline lower with shares
|
| 4/10/2014 | CV | Market Commentary: Convertibles mostly steady, some vol. names up as equities slide; WellPoint flat; AMAG slips
|
| 4/9/2014 | CV | Market Commentary: Midday Commentary: Convertibles mostly quiet; WellPoint trades higher in active trade
|
| 4/9/2014 | CV | Market Commentary: WellPoint flat to higher in active trade; larger, higher-grade issues trade; RPM in focus
|
| 3/24/2014 | CV | Market Commentary: Midday Commentary: WellPoint's long bonds rise in early trade; Tesla flat on weaker shares
|
| 2/11/2014 | CV | Market Commentary: Planned AMAG looks cheap; Canadian Solar launches; WebMD slips outright, adds on hedge
|
| 2/7/2014 | CV | Market Commentary: New PDL BioPharma trades up outright, mixed on hedge; existing PDL up with exchange offer
|
| 1/29/2014 | CV | Market Commentary: Midday Commentary: Fluidigm launches $175 million convertible; WellPoint lower after earnings
|
| 1/29/2014 | CV | Market Commentary: Fluidigm talk tightened; Medivation jumps on positive trial data; Illumina trades in line
|
| 1/28/2014 | CV | Market Commentary: WellPoint slips in line with shares; AK Steel surges after earnings beat; Regis moves up
|
| 7/30/2013 | CVIG | Moody's: WellPoint notes Baa2
|
| 7/30/2013 | CVIG | S&P gives WellPoint debt A-
|
| 7/30/2013 | CVIG | Fitch to rate WellPoint notes BBB+
|
| 7/22/2013 | CV | Market Commentary: Convertibles mostly quiet as traders eye upcoming earnings; older Jakks extends losses
|
| 7/5/2013 | CV | Market Commentary: Convertibles quiet after holiday; 'soft' market eyed after job report pushes rates higher
|
| 2/13/2013 | CV | Market Commentary: BlackRock Kelso flat; planned Cliffs wrestles borrow; Starwood up; WellPoint flat to lower
|
| 10/17/2012 | CV | Market Commentary: Intel flat to lower outright, up on hedge; Knight firm; Stillwater, WellPoint doing well
|
| 10/9/2012 | CV | WellPoint greenshoe exercised, lifting convertibles to $1.5 billion
|
| 10/5/2012 | CV | Market Commentary: Convertibles mostly quiet; WellPoint puts in notably strong week; Home Inns drops on swap
|
| 10/4/2012 | CV | Market Commentary: New Ares Capital flat after pricing at discount; WellPoint gains; NuVasive loses on hedge
|
| 10/3/2012 | CV | Market Commentary: New WellPoint up on debut; Ares Capital on tap; existing Ares paper quiet; NuVasive drops
|
| 10/2/2012 | CV | Market Commentary: WellPoint adds in the gray, models attractively; Molina, Amerigroup quiet; Illumina eyed
|
| 10/2/2012 | CVIG | S&P: WellPoint notes A
|
| 10/2/2012 | CV | New Issue: WellPoint prices $1.35 billion 30-year convertible debentures to yield 2.75%, up 25%
|
| 10/1/2012 | CV | Market Commentary: Lam Research trades actively; Molson Coors 'in' slightly; WellPoint offers $1.35 billion
|
| 10/1/2012 | CV | WellPoint plans $1.35 billion 30-year convertible debentures to yield 2.5%-3%, up 20%-25%
|
| 12/9/2011 | CVIGPF | WellPoint files automatic shelf for debt, preferreds and stock
|
| 12/12/2008 | CVIG | WellPoint files automatic shelf registration
|
| 2/26/2007 | CV | S&P: No change for WellPoint
|
| 5/24/2006 | CV | S&P boosts WellPoint outlook to positive
|
| 1/6/2006 | CV | S&P gives WellPoint notes BBB+
|
| 1/6/2006 | CV | Fitch assigns WellPoint notes A-
|
| 12/30/2005 | CV | WellPoint files debt, stock shelf
|
| 12/7/2005 | CV | New Issue: Morgan Stanley prices $31.52 million 20% Perqs exchangeable for WellPoint
|
